These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11227020)
1. Current problems of amebiasis in Japan and recent advances in amebiasis research. Nozaki T Jpn J Infect Dis; 2000 Dec; 53(6):229-37. PubMed ID: 11227020 [TBL] [Abstract][Full Text] [Related]
2. Diversity of clinical isolates of Entamoeba histolytica in Japan. Nozaki T; Kobayashi S; Takeuchi T; Haghighi A Arch Med Res; 2006 Feb; 37(2):277-9. PubMed ID: 16380332 [TBL] [Abstract][Full Text] [Related]
7. Overview of Entamoeba histolytica and amebiasis in Korea with special reference to research notes. Soh CT Kisaengchunghak Chapchi; 1990 Dec; 28 Suppl():13-27. PubMed ID: 2133418 [TBL] [Abstract][Full Text] [Related]
8. Amebiasis: human infection with Entamoeba histolytica. Kelsall BL; Ravdin JI Prog Clin Parasitol; 1994; 4():27-54. PubMed ID: 7948936 [No Abstract] [Full Text] [Related]
9. [Relevance of Entamoeba dispar in amebiasis]. Chacín-Bonilla L Invest Clin; 2001 Sep; 42(3):157-9. PubMed ID: 11552504 [TBL] [Abstract][Full Text] [Related]
10. Entamoeba thiol-based redox metabolism: A potential target for drug development. Jeelani G; Nozaki T Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086 [TBL] [Abstract][Full Text] [Related]
11. Amebiasis and the Entamoeba histolytica Gal/GalNAc lectin: from lab bench to bedside. Petri Wa J Investig Med; 1996 Feb; 44(2):24-36. PubMed ID: 8689398 [No Abstract] [Full Text] [Related]
12. Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Hung CC; Deng HY; Hsiao WH; Hsieh SM; Hsiao CF; Chen MY; Chang SC; Su KE Arch Intern Med; 2005 Feb; 165(4):409-15. PubMed ID: 15738369 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the redefinition of the agent of amoebiasis. Lucas R; Upcroft JA Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507 [TBL] [Abstract][Full Text] [Related]
14. [Virulence of E. histolytics strains and its modification in the process of cultivation]. Zaslavskaia IV Med Parazitol (Mosk); 1975; 44(2):192-5. PubMed ID: 175254 [No Abstract] [Full Text] [Related]
15. Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis. Mi-Ichi F; Tsugawa H; Vo TK; Kurizaki Y; Yoshida H; Arita M PLoS Pathog; 2024 Aug; 20(8):e1012435. PubMed ID: 39172749 [TBL] [Abstract][Full Text] [Related]
17. Observations on zymodeme studies of Entamoeba histolytica in Durban, South Africa. Jackson TF; Sargeaunt PG; Williams JE; Simjee AE Arch Invest Med (Mex); 1982; 13 Suppl 3():83-8. PubMed ID: 6295333 [No Abstract] [Full Text] [Related]
18. Indications for treatment. Apt W Int J Parasitol; 1987 Feb; 17(1):141-9. PubMed ID: 2884194 [No Abstract] [Full Text] [Related]
19. Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis. Morán P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C Am J Trop Med Hyg; 2005 Aug; 73(2):296-300. PubMed ID: 16103593 [TBL] [Abstract][Full Text] [Related]
20. Studies on Entamoeba histolytica infection in rural localities in Banat. Sorescu A; Silard R; Panaitescu D; Lupaşcu G; Costin P Arch Roum Pathol Exp Microbiol; 1982; 41(4):371-4. PubMed ID: 6303273 [No Abstract] [Full Text] [Related] [Next] [New Search]